Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 15INDUSTRY 13NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Urinary Bladder Neoplasms 18Pancreatic Neoplasms 17Lung Neoplasms 14Carcinoma, Non-Small-Cell Lung 14Biliary Tract Neoplasms 10Urethral Neoplasms 9Lymphoma 8Uterine Cervical Neoplasms 6Ovarian Neoplasms 6Gallbladder Neoplasms 6Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Large-Cell, Anaplastic 4Hodgkin Disease 4Carcinoma, Ovarian Epithelial 4Breast Neoplasms 4Sarcoma 3Kidney Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Bile Duct Neoplasms 3Salivary Gland Neoplasms 2Recurrent Uterine Corpus Sarcoma 2Recurrence 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Lymphoma, Non-Hodgkin 2Immunoblastic Lymphadenopathy 2Fallopian Tube Neoplasms 2Adenocarcinoma of Lung 2

Interventions

Radiotherapy 2Gemcitabine 2Docetaxel 1BCG Vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Non-Muscle Invasive Bladder Neoplasms × Gemcitabine × Clear all
NCT05538663 2026-05-05

BRIDGE

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
870 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT06972615 2026-02-17

Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy

BLATAM

Phase 2 Not yet recruiting
37 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡